Evidence map›Paper›PMID 41839767›Full record

ArticleJournal of the American Chemical Society2026

Molecular Dynamics-Guided Design and Chemoproteomic Profiling of Covalent Kinase Activity Probes.

Pratyasha Chakraborty, Anthony Carlos, Trayder Thomas, Kyle Ghaby, Shaghayegh Fathi, Mukta Sharma, Ngoc Kim Nguyen, Mason Farmwald, Lydia Blachowicz, Emma Alcyone and 5 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Pratyasha ChakrabortyDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Anthony CarlosDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0003-0021-2348
Trayder ThomasDepartment of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois 60637, United States.
Kyle GhabyDepartment of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0002-6071-9274
Shaghayegh FathiDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Mukta SharmaDepartment of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois 60637, United States.
Ngoc Kim NguyenDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Mason FarmwaldDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Lydia BlachowiczDepartment of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois 60637, United States.
Emma AlcyoneDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Keira HarterDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Shaopeng YuDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Kavya Smitha PillaiDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Benoît RouxDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0002-5254-2712
Raymond E MoelleringDepartment of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0002-2043-7838

Funding

Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Conformational Flexibility in Activation of Src-KinaseR01CA093577 · NCI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI BENOIT ROUX · 2002 to 2026
$5.6M
Mapping Protein Social Network Dynamics with Photoproximity Profiling PlatformsR01GM145852 · NIGMS · UNIVERSITY OF CHICAGO · PI MOELLERING, RAYMOND E · 2022 to 2025
$1.5M
Role of BNIP3 and mitophagy in muscle atrophy and cancer cachexiaR01CA294703 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD · 2025 to 2026
$1.4M
Single-Cell Protein Activity Profiling in Breast Cancer Cells and TissuesR33CA269094 · NCI · UNIVERSITY OF CHICAGO · PI MOELLERING, RAYMOND E · 2022 to 2024
$1.1M
NCI NIH HHS R01 CA093577NCI NIH HHS R01 CA294703NCI NIH HHS R33 CA269094NCI NIH HHS T32 CA009594NIGMS NIH HHS R01 GM145852
6 · The paper itself

Abstract

Covalent small molecule probes can be powerful tools to interrogate protein activity state in native cellular environments. The design of familywide activity probes requires an understanding of the molecular sources of conserved and target-specific small molecule targeting across protein family members. Here, we developed and applied a multifaceted docking and molecular dynamics (MD) simulation pipeline to design cell-permeable covalent kinase activity probes from a set of hinge-binding pharmacophores. This computationally-guided approach yielded a series of cell-active indazole sulfonylfluorides that target a conserved catalytic lysine in active protein kinases. Chemoproteomic profiling of a lead probe, K60P, confirmed engagement of more than 100 unique native kinases across several cancer cell lines. Competitive profiling identified kinases as the predominant class of specific targets for K60P but also highlighted significant nonkinase targets for K60P and the established covalent kinase probe, XO44, underscoring the utility of native kinase profiling in situ to identify relevant targets of small molecule kinase inhibitors in cells. Dose-, time- and site-specific proteomic mapping with a known target kinase, ABL1, coupled with a Bayesian Metropolis Monte Carlo (BMMC) kinetic modeling method showed that key descriptors of covalent probe efficiency could be predicted with straightforward dose- and time-dependent covalent engagement studies and highlighted

Indexed as

Drug DesignIndazolesMolecular Dynamics SimulationMolecular ProbesProtein Kinase InhibitorsProtein KinasesProteomicsCell Line, TumorHumansIndazolesMolecular ProbesProtein Kinase InhibitorsProtein Kinases

Identifiers

PMID41839767
PMCPMC13137389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.